Cite
Siegrist R, Pozzi D, Jacob G, et al. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017;60(5):2163doi: 10.1021/acs.jmedchem.7b00219.
Siegrist, R., Pozzi, D., Jacob, G., Torrisi, C., Colas, K., Braibant, B., Mawet, J., Pfeifer, T., de Kanter, R., Roch, C., Kessler, M., Moon, R., Corminboeuf, O., & Bezençon, O. (2017). Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. Journal of medicinal chemistry, 60(5), 2163. https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist, Romain, et al. "Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers." Journal of medicinal chemistry vol. 60,5 (2017): 2163. doi: https://doi.org/10.1021/acs.jmedchem.7b00219
Siegrist R, Pozzi D, Jacob G, Torrisi C, Colas K, Braibant B, Mawet J, Pfeifer T, de Kanter R, Roch C, Kessler M, Moon R, Corminboeuf O, Bezençon O. Correction to Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers. J Med Chem. 2017 Mar 09;60(5):2163. doi: 10.1021/acs.jmedchem.7b00219. Epub 2017 Feb 24. PMID: 28234473.
Copy
Download .nbib